Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial

Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    An NIH grant/contract entry was added to the study identifiers, indicating NIH funding associated with the trial.
    Difference
    0.0%
    Check dated 2026-08-27T15:32:47.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5 in the study documentation. This indicates a minor, internal update to the study materials.
    Difference
    0.0%
    Check dated 2026-08-13T11:31:29.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4. This reflects a minor metadata update to the document without changes to visible content.
    Difference
    0.0%
    Check dated 2026-07-23T05:47:36.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new publication citation has been added under Publications describing a study on ENVISION trial data related to the investigational agent and IgA nephropathy; it indicates ongoing dissemination of related research.
    Difference
    0.0%
    Check dated 2026-07-15T23:46:28.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.3. This indicates a newer version of the study documentation associated with the page.
    Difference
    0.0%
    Check dated 2026-07-01T10:52:49.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed with 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and records the latest Revision: v3.6.0 document.
    Difference
    0.2%
    Check dated 2026-06-16T01:13:06.000Z thumbnail image

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.